Kosj Yamoah, Ph.D. - Publications

Affiliations: 
2006 Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Molecular Biology, Oncology

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Naghavi AO, Echevarria MI, Strom TJ, Abuodeh YA, Ahmed KA, Venkat PS, Trotti A, Harrison LB, Green BL, Yamoah K, Caudell JJ. Treatment delays, race, and outcomes in head and neck cancer. Cancer Epidemiology. 45: 18-25. PMID 27664388 DOI: 10.1016/J.Canep.2016.09.005  0.72
2016 Yamoah K, Zeigler-Johnson CM, Jeffers A, Malkowicz B, Spangler E, Park JY, Whittemore A, Rebbeck TR. The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer. Bmc Cancer. 16: 557. PMID 27473687 DOI: 10.1186/S12885-016-2572-Y  0.72
2015 Yamoah K, Johnson MH, Choeurng V, Faisal FA, Yousefi K, Haddad Z, Ross AE, Alshalafa M, Den R, Lal P, Feldman M, Dicker AP, Klein EA, Davicioni E, Rebbeck TR, et al. Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26195723 DOI: 10.1200/Jco.2014.59.8912  0.72
2015 Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Martei Y, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM. Corrigendum: "Training Global Oncologists: Addressing the Global Cancer Control Problem". Frontiers in Oncology. 5: 133. PMID 26114095 DOI: 10.3389/Fonc.2015.00133  0.72
2015 Palmer JD, Siglin J, Yamoah K, Dan T, Champ CE, Bar-Ad V, Werner-Wasik M, Evans JJ, Kim L, Glass J, Farrell C, Andrews DW, Shi W. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better. Journal of Neuro-Oncology. PMID 26024653 DOI: 10.1007/S11060-015-1825-Y  0.72
2015 Eldredge-Hindy HB, Duffy D, Yamoah K, Simone NL, Skowronski J, Dicker AP, Anne PR. Modeled risk of ischemic heart disease following left breast irradiation with deep inspiration breath hold. Practical Radiation Oncology. 5: 162-8. PMID 25957186 DOI: 10.1016/J.Prro.2014.10.002  0.72
2015 Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SM. Training global oncologists: addressing the global cancer control problem. Frontiers in Oncology. 5: 80. PMID 25905040 DOI: 10.3389/Fonc.2015.00080  0.72
2015 Yamoah K, Walker A, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Dicker AP, Rebbeck TR, Lal P. African-american race is a predictor of seminal vesicle invasion after radical prostatectomy. Clinical Genitourinary Cancer. 13: e65-72. PMID 25450037 DOI: 10.1016/j.clgc.2014.08.012  0.72
2015 Yamoah K, Deville C, Vapiwala N, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Kattan M, Dicker AP, Rebbeck TR. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urologic Oncology. 33: 70.e15-22. PMID 25304288 DOI: 10.1016/J.Urolonc.2014.07.005  0.72
2014 Yamoah K, Eldredge-Hindy HB, Zaorsky NG, Palmer JD, Doyle LA, Sendecki JA, Hesney AA, Harper L, Repka M, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 13: 456-64. PMID 24953945 DOI: 10.1016/J.Brachy.2014.04.003  0.72
2014 Zaorsky NG, Yamoah K, Thakur ML, Trabulsi EJ, Showalter TN, Hurwitz MD, Dicker AP, Den RB. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer. Future Oncology (London, England). 10: 457-74. PMID 24559451 DOI: 10.2217/Fon.13.196  0.72
2014 Zaorsky NG, Doyle LA, Yamoah K, Andrel JA, Trabulsi EJ, Hurwitz MD, Dicker AP, Den RB. High dose rate brachytherapy boost for prostate cancer: a systematic review. Cancer Treatment Reviews. 40: 414-25. PMID 24231548 DOI: 10.1016/J.Ctrv.2013.10.006  0.72
2013 Yamoah K, Beecham K, Hegarty SE, Hyslop T, Showalter T, Yarney J. Early results of prostate cancer radiation therapy: an analysis with emphasis on research strategies to improve treatment delivery and outcomes. Bmc Cancer. 13: 23. PMID 23324165 DOI: 10.1186/1471-2407-13-23  0.72
2011 Yamoah K, Stone N, Stock R. Impact of race on biochemical disease recurrence after prostate brachytherapy. Cancer. 117: 5589-600. PMID 21692058 DOI: 10.1002/Cncr.26183  0.72
2008 Fang L, Wang X, Yamoah K, Chen PL, Pan ZQ, Huang L. Characterization of the human COP9 signalosome complex using affinity purification and mass spectrometry. Journal of Proteome Research. 7: 4914-25. PMID 18850735 DOI: 10.1021/Pr800574C  0.72
2008 Yamoah K, Oashi T, Sarikas A, Gazdoiu S, Osman R, Pan ZQ. Autoinhibitory regulation of SCF-mediated ubiquitination by human cullin 1's C-terminal tail. Proceedings of the National Academy of Sciences of the United States of America. 105: 12230-5. PMID 18723677 DOI: 10.1073/Pnas.0806155105  0.72
2008 Sun L, Vukicevic S, Baliram R, Yang G, Sendak R, McPherson J, Zhu LL, Iqbal J, Latif R, Natrajan A, Arabi A, Yamoah K, Moonga BS, Gabet Y, Davies TF, et al. Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proceedings of the National Academy of Sciences of the United States of America. 105: 4289-94. PMID 18332426 DOI: 10.1073/Pnas.0712395105  0.72
2008 Yamoah K, Brebene A, Baliram R, Inagaki K, Dolios G, Arabi A, Majeed R, Amano H, Wang R, Yanagisawa R, Abe E. High-mobility group box proteins modulate tumor necrosis factor-alpha expression in osteoclastogenesis via a novel deoxyribonucleic acid sequence. Molecular Endocrinology (Baltimore, Md.). 22: 1141-53. PMID 18218727 DOI: 10.1210/Me.2007-0460  0.72
2007 Abe E, Sun L, Mechanick J, Iqbal J, Yamoah K, Baliram R, Arabi A, Moonga BS, Davies TF, Zaidi M. Bone loss in thyroid disease: role of low TSH and high thyroid hormone. Annals of the New York Academy of Sciences. 1116: 383-91. PMID 18083940 DOI: 10.1196/Annals.1402.062  0.72
2007 Kumar A, Wu H, Collier-Hyams LS, Hansen JM, Li T, Yamoah K, Pan ZQ, Jones DP, Neish AS. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. The Embo Journal. 26: 4457-66. PMID 17914462 DOI: 10.1038/Sj.Emboj.7601867  0.72
2007 Gazdoiu S, Yamoah K, Wu K, Pan ZQ. Human Cdc34 employs distinct sites to coordinate attachment of ubiquitin to a substrate and assembly of polyubiquitin chains. Molecular and Cellular Biology. 27: 7041-52. PMID 17698585 DOI: 10.1128/Mcb.00812-07  0.72
2007 Sun L, Peng Y, Zaidi N, Zhu LL, Iqbal J, Yamoah K, Wang X, Liu P, Abe E, Moonga BS, Epstein S, Zaidi M. Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts. American Journal of Physiology. Renal Physiology. 292: F285-91. PMID 16968888 DOI: 10.1152/Ajprenal.00415.2005  0.72
2005 Yamoah K, Wu K, Pan ZQ. In vitro cleavage of Nedd8 from cullin 1 by COP9 signalosome and deneddylase 1. Methods in Enzymology. 398: 509-22. PMID 16275355 DOI: 10.1016/S0076-6879(05)98042-7  0.72
2005 Gazdoiu S, Yamoah K, Wu K, Escalante CR, Tappin I, Bermudez V, Aggarwal AK, Hurwitz J, Pan ZQ. Proximity-induced activation of human Cdc34 through heterologous dimerization. Proceedings of the National Academy of Sciences of the United States of America. 102: 15053-8. PMID 16210246 DOI: 10.1073/Pnas.0507646102  0.72
2004 Pan ZQ, Kentsis A, Dias DC, Yamoah K, Wu K. Nedd8 on cullin: Building an expressway to protein destruction Oncogene. 23: 1985-1997. PMID 15021886 DOI: 10.1038/Sj.Onc.1207414  0.72
2003 Wu K, Yamoah K, Dolios G, Gan-Erdene T, Tan P, Chen A, Lee CG, Wei N, Wilkinson KD, Wang R, Pan ZQ. DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1. The Journal of Biological Chemistry. 278: 28882-91. PMID 12759363 DOI: 10.1074/Jbc.M302888200  0.72
Show low-probability matches.